C/EBPβ-Induced Alternative Splicing of RCAN1 Generates a Potent TCR-T Target in Mesenchymal Glioblastoma

Researchers reported RCAN1-4 as a novel tumor antigen derived from alternative splicing induced by the transcription factor C/EBPβ.